Permitted Daily Exposure Calculated

The importance of Health-based Exposure Limits (HBEL) through scientific toxicological risk assessment has grown in the pharmaceutical industry since the implementation of the European Medicines Agency's (EMA) 'Guideline on setting 'Health-based exposure limits for risk identification in shared facilities production of various medical items (EMA/CHMP/CVMP/SWP/169430/2012)'.

Calculations for PDE (Permitted Daily Exposure) and ADE (Acceptable Daily Exposure).

The EMA guideline asks for the development of HBELs to be utilised in evaluating the risks of residual active substance contamination through pharmaceutical products. Derivation and establishment of PermittedDaily Exposure (PDE), also known as AcceptableDaily Exposure (ADE), has thus become an integral part of the cleaning validation programme for pharmaceutical manufacturing facilities or Contract Manufacturing Organizations (CMOs), in order to comply with various Regulatory or cGMP requirements.

The use of PDE/ADE values produced from a scientific and toxicological risk assessment of clinical and non-clinical data can be used to manage or restrict the potential risk of cross-contamination. Identification of risks through a structured and strategized literature search, identification of critical effects, establishment of NOEL/NOAEL for critical effects, and application of the PDE are all processes in the PDE calculation. According to the EMA, 2014, ICH Q3C, ISPE, and VICH GL18, bioavailability adjustment variables for a route to route extrapolation. In manufacturing plants, the PDE/ADE values are utilised in cleaning validation to calculate the maximum possible carryover (MACO values). Most hazardous compounds, such as cytotoxic medicines, hormones, and steroids, have PDE/ADE values that assist in determining the need for dedicated and separate equipment and facilities.

Calculating and banding Occupational Exposure Limits (OELs)

The highest airborne level of a chemical to which most employees could be exposed without adverse health effects or impacts is known as the Occupational Exposure Limit (OEL). Milligrams of contaminant per cubic metre of air (mg/m3) is the most used unit of measurement for exposure limits. Skin notation is also used to highlight the possibility of skin absorption and how much skin absorption contributes to the overall exposure. OELs are a standard for limiting worker exposure to hazardous substances at work. The OEL is determined by taking into account all available information on a substance's dangers, particularly in terms of acute and chronic toxicity, carcinogenicity, mutagenicity, and reproductive toxicity.

The Occupational Safety and Health Administration (OSHA) and several other agencies, including the American Conference of Governmental Industrial Hygienists (ACGIH), the National Institutes of Occupational Safety and Health (NIOSH), the Japan Society for Occupational Health (JSOH), and the European Chemical Agency, have recommended the OEL calculation for pharmaceuticals, despite the fact that it is not required (ECHA).

Our Expertise

FTI Incorporation have created and delivered over 2500+ high-quality PDE/ADE reports/monographs in compliance with EMA, ISPE, ASTM, and other country-specific criteria over the years. PDE/ADE reports for oral, parenteral, inhalation, topical, and some of the more uncommon routes, such as ophthalmic and otic, have been created by FTI Incorporation and have been based on a thorough scrutiny during GMP inspections and critical evaluations by our clients' in-house toxicologists.

For a complete list of FTI Incorporation molecules, agents, and PDE reports, please Contact Us. We will happily share it with you as soon as possible.